| ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies KL Hayward, AL Johnson, BJ Mckillen, NT Burke, V Bansal, LU Horsfall, ... BMJ Open Gastroenterology 7 (1), e000485, 2020 | 32 | 2020 |
| Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM KL Hayward, AL Johnson, LU Horsfall, C Moser, PC Valery, EE Powell BMJ Open Gastroenterology 8 (1), e000572, 2021 | 30 | 2021 |
| Predicting liver‐related outcomes in people with nonalcoholic fatty liver disease: the prognostic value of noninvasive fibrosis tests AL Johnson, KL Hayward, P Patel, LU Horsfall, AEZ Cheah, KM Irvine, ... Hepatology Communications 6 (4), 728-739, 2022 | 23 | 2022 |
| Managing medicines in alcohol-associated liver disease: a practical review AL Johnson, KL Hayward Australian Prescriber 44 (3), 96, 2021 | 5 | 2021 |
| Towards collaborative management of non‐alcoholic fatty liver disease: a ‘real‐world’pathway for fibrosis risk assessment in primary care KL Hayward, BJ McKillen, LU Horsfall, C McIvor, K Liew, J Sexton, ... Internal Medicine Journal 52 (10), 1749-1758, 2022 | 4 | 2022 |
